Equillium Buys Metacrine For Its Cash, Will Outsource Lead Drug Candidate

All-Stock Deal Merges Two San Diego Firms

Isometric arrow formed by two merging black and white lines on turquoise blue
Equillium will use Metacrine's cash for its own programs • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business